GLRE vs JAZZ · P/E 10, rev $327.1M vs P/E 1988, rev $2.28B
Greenlight Capital Re Ltd (GLRE) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Greenlight Capital Re Ltd (GLRE) is a insurance - reinsurance company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported GLRE revenue for 2026-06-30 was $327.1M. Net income was $6.2M. Revenue was up 72.5% from 2026-03-31 to 2026-06-30. GLRE currently screens at market cap $478.2M and trailing P/E 10.5.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
GLRE currently screens at market cap $478.2M and trailing P/E 10.5. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the GLRE and JAZZ stock pages for the full models.
Not investment advice.